534.8500 -8.40 (-1.55%)
NSE Jun 05, 2026 15:31 PM
Volume: 98,310
 

534.85
-1.55%
Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. is trading above its 150 day SMA of 522.0
More from Solara Active Pharma Sciences Ltd.
Recommended